Jong H Choi1, Jaemin Lee, Chong M Park. 1. Department of Anesthesiology, School of Medicine, The Catholic University of Korea, Kangnam Saint Mary's Hospital, 505 Banpo-Dong, Seocho-Gu, Seoul, Korea 137-040.
Abstract
PURPOSE: Patients undergoing liver transplantation may be predisposed to hypomagnesemia and present a bleeding tendency. There are evidences suggesting that magnesium is a crucial constituent of the blood coagulation cascade and has a pro-coagulant activity. The aim of this study was to investigate the effect of magnesium therapy on thromboelastography (TEG) in patients undergoing liver transplantation. METHODS: 27 patients scheduled for liver transplantation were enrolled. 1.5 g of magnesium sulfate, diluted in normal saline, were infused to all patients over five minutes in the operating room, before skin incision. The TEG findings immediately before and ten minutes after the magnesium infusion were compared. RESULTS: The TEG findings showed general hypocoagulability before magnesium therapy. The K time and coagulation times (r+k) were shortened significantly from 641.6 +/- 505.9 (mean +/- SD) to 464.6 +/- 387.7 sec and from 1664.7 +/- 772.5 to 1362.2 +/- 487.1 sec respectively (P < 0.05); the maximal amplitude, and TEG index showed significant increases from 38.5 +/- 13.5 to 45.3 +/- 12.2 mm and from -3.4 +/- 2.6 to -1.9 +/- 1.8 respectively after magnesium therapy (P < 0.01). R time, alpha angle and LY60 were not different after magnesium therapy. CONCLUSION: Magnesium therapy significantly improved TEG findings suggestive of a general hypocoagulable state towards normal in patients about to receive liver transplantation.
PURPOSE:Patients undergoing liver transplantation may be predisposed to hypomagnesemia and present a bleeding tendency. There are evidences suggesting that magnesium is a crucial constituent of the blood coagulation cascade and has a pro-coagulant activity. The aim of this study was to investigate the effect of magnesium therapy on thromboelastography (TEG) in patients undergoing liver transplantation. METHODS: 27 patients scheduled for liver transplantation were enrolled. 1.5 g of magnesium sulfate, diluted in normal saline, were infused to all patients over five minutes in the operating room, before skin incision. The TEG findings immediately before and ten minutes after the magnesium infusion were compared. RESULTS: The TEG findings showed general hypocoagulability before magnesium therapy. The K time and coagulation times (r+k) were shortened significantly from 641.6 +/- 505.9 (mean +/- SD) to 464.6 +/- 387.7 sec and from 1664.7 +/- 772.5 to 1362.2 +/- 487.1 sec respectively (P < 0.05); the maximal amplitude, and TEG index showed significant increases from 38.5 +/- 13.5 to 45.3 +/- 12.2 mm and from -3.4 +/- 2.6 to -1.9 +/- 1.8 respectively after magnesium therapy (P < 0.01). R time, alpha angle and LY60 were not different after magnesium therapy. CONCLUSION:Magnesium therapy significantly improved TEG findings suggestive of a general hypocoagulable state towards normal in patients about to receive liver transplantation.
Authors: Mohammad Ali Sahmeddini; Ashkan Taghizadehimani; Mohammad Bagher Khosravi; Mohammad Hossein Eghbal Journal: Indian J Hematol Blood Transfus Date: 2020-02-24 Impact factor: 0.900
Authors: Eric M Liotta; Ameeta Karmarkar; Ayush Batra; Minjee Kim; Shyam Prabhakaran; Andrew M Naidech; Matthew B Maas Journal: Crit Care Med Date: 2020-01 Impact factor: 7.598
Authors: Matthew B Maas; Babak S Jahromi; Ayush Batra; Matthew B Potts; Andrew M Naidech; Eric M Liotta Journal: Stroke Date: 2020-08-10 Impact factor: 7.914
Authors: Eric M Liotta; Shyam Prabhakaran; Rajbeer S Sangha; Robin A Bush; Alan E Long; Stephen A Trevick; Matthew B Potts; Babak S Jahromi; Minjee Kim; Edward M Manno; Farzaneh A Sorond; Andrew M Naidech; Matthew B Maas Journal: Neurology Date: 2017-07-26 Impact factor: 9.910